Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)

Merck Sharp & Dohme LLC · NCT07743151

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–64 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
400
US sites recruiting
6
Study start
September 10, 2026
Record last updated
October 20, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this trial is to compare what happens to MK-1406 in the body of healthy participants when it is given as 2-injections and 3-injections. Researchers also want to learn about the safety of MK-1406 and if people tolerate it.

Being studied: MK-1406

Conditions: Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

The main inclusion criteria include but are not limited to the following:

  • Is in good health
  • Has body mass index (BMI) 18.0 to 32.0 kg/m\^2

Exclusion Criteria

The main exclusion criteria include but are not limited to the following:

  • History of clinically significant endocrine, Gastrointestinal (GI), cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases
  • History of cancer (malignancy)

Recruiting US locations

  • Research Centers of America ( Hollywood ) ( Site 0008)

    Hollywood, FL 33024

    Site contact: Study Coordinator · 954-990-7649

  • QPS-MRA, LLC ( Site 0007)

    South Miami, FL 33143

    Site contact: Study Coordinator · 305-722-0970

  • Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0002)

    Springfield, MO 65802

    Site contact: Study Coordinator · 417-831-2048

  • Hassman Research Institute Marlton Site ( Site 0001)

    Marlton, NJ 08053

    Site contact: Study Coordinator · 856-452-9901

  • Velocity Clinical Research, Cleveland ( Site 0005)

    Cleveland, OH 44122

    Site contact: Study Coordinator · 216-682-0320

  • ICON Early Phase Services ( Site 0004)

    San Antonio, TX 78232

    Site contact: Study Coordinator · 210-225-5437

Study contacts (from the official record)

  • Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
All healthy volunteers studies in Florida →
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008) (NCT07743151) | Bored Studies